Insights
Latest insights from Cortado Ventures’ Team, Founders and Network
Startups 101: Common Mistakes Startups Make & How To Fix Them
Cody’s Insights: The Biggest Mistakes Startups Make and How to Avoid Them
Pipedream Labs: Raises $13M for Underground Delivery
Pipedream Labs has raised over $13 million
Sensulin: Introducing the Most Affordable Smart Insulin to the Market
Sensulin Biotech, an Oklahoma startup, is bringing the lowest-cost Smart Insulin to the market
Empowering Women in Legacy Sectors: Celebrating Innovators in Manufacturing and Supply Chain
Susan features Charu Thomas, Haley Keith, and Lisa Mullen.
Why We Invested: Cadenza Bio
Cortado Ventures invests in Cadenza Bio
Cody Merrill: A Cortado Conversation with CorriXR Therapeutics CEO Deborah Moorad
CorriXR Therapeutics is the first spinout of ChristianaCare, a large Delaware-based healthcare system
Nathaniel Harding: Year in Review and 2024 Outlook
Let’s look back at 2023 for VC and our firm to set the stage for an exciting 2024
Why We Invested: Lumata Health
Why We Invested: Lumata Health Pioneering Next-Generation Eye Care Authored by Cody Merrill At Cortado Ventures, we are in the venture capital business of maximizing risk-adjusted returns with high-potential, early-stage startups. We seek...
Cadenza Bio, Inc. Secures $2.44M in Oversubscribed Series Seed Financing
Preclinical biotechnology company initially focusing on therapeutic drug development to promote remyelination in Multiple Sclerosis OKLAHOMA CITY, Dec. 14, 2023 /PRNewswire/ -- Cadenza Bio, Inc. (Cadenza), a privately-held biotechnology company focused on developing...